Gene delivery from the E3 region of replicating human adenovirus: evaluation of the ADP region (Q43710400)

26 November 2017

title

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the ADP region (English)

1 reference

26 November 2017

1 reference

Hawkins LK

1 reference

26 November 2017

Hermiston TW

series ordinal

1 reference

26 November 2017

publication date

1 August 2001

1 reference

26 November 2017

1 reference

26 November 2017

1 reference

26 November 2017

1 reference

26 November 2017

page(s)

1132-1141

1 reference

Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

Replication-selective adenoviruses as oncolytic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

Generation of adenovirus by transfection of plasmids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the E3B region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

Molecular cloning of the complementary DNA for human tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

An endotoxin-induced serum factor that causes necrosis of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

Tumor necrosis factor-alpha and Fas activate complementary Fas-associated death domain-dependent pathways that enhance apoptosis induced by gamma-irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

Tumor necrosis factor induces tumor necrosis via tumor necrosis factor receptor type 1-expressing endothelial cells of the tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

Phase I study of recombinant human tumor necrosis factor alpha in advanced malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

Cytokines and immunity to viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

Adenovirus proteins that subvert host defenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

The role of tumor necrosis factor in viral disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

Rapid insertional mutagenesis of DNA by polymerase chain reaction (PCR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

ONYX-015: clinical data are encouraging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

7 January 2021

Fine-mapping of sequences that suppress splicing in the E3 complex transcription unit of adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

7 January 2021

Limb desmoid tumors: a possible role for isolated limb perfusion with tumor necrosis factor-alpha and melphalan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

7 January 2021

Recombinant human tumor necrosis factor-alpha: thrombus formation is a cause of anti-tumor activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

7 January 2021

In vitro remodeling of tumor vascular endothelial cells using conditioned medium from various tumor cells and their sensitivity to TNF-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301508

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301508

1 reference

Dimensions Publication ID

26 November 2017

1007414000

0 references

1 reference